Executive Medical Director - Physician - Early Clinical Development, Aesthetic Medicine

Eli Lilly and Company; Indianapolis (IN); On-site; USD 300,000 - 460,000; Full time

Job summary

Scorpion Therapeutics seeks an Executive Medical Director, Early Clinical Development in Aesthetic Medicine to lead translational and clinical strategies for innovative aesthetic dermatologic treatments. You will shape hypotheses, design early studies, and guide cross-functional teams in pursuit of skin health and aesthetic therapeutics.

The role requires MD/DO with board certification in dermatology or plastic surgery and 5+ years in early clinical development, with experience in regulatory and

Qualifications

• MD or DO required, board eligible/certified in Dermatology, Plastic Surgery, or related specialty
• 5+ years pharma/biotech industry experience in early clinical development
• Proven leadership in translational medicine and biomarker development
• Experience in designing early clinical trials and regulatory interactions

Responsibilities

• Develop and refine therapeutic hypotheses and early clinical study designs
• Collaborate with discovery, biomarker, clinical pharmacology, and regulatory teams
• Lead regulatory interactions and contribute to external scientific engagement
• Influence portfolio direction and lead translational strategy for aesthetic dermatology programs

Skills

Translational medicine

Clinical trial design

Leadership

Cross-functional collaboration

Education

MD/DO degree

Board certification in Dermatology or Plastic Surgery

PhD in Skin Biology (preferred)

Job description

Role:

Executive Medical Director, Early Clinical Development in Aesthetic Medicine, leading translational and clinical strategies to develop innovative aesthetic dermatologic treatments.

Responsibilities:

develop and refine therapeutic hypotheses, design early clinical studies, collaborate with cross-functional teams (discovery, biomarker, clinical pharmacology, regulatory), and evaluate external partnership opportunities. Serve as a scientific and strategic leader, influencing portfolio direction and advancing transformational medicines for skin health, facial, and body aesthetics. Lead regulatory interactions and contribute to medical and scientific external engagement.

Requirements:

MD or DO, board eligible/certified in Dermatology, Plastic Surgery, or related specialty; 5+ years pharma/biotech industry experience in early clinical development, with proven leadership in translational medicine, biomarker development, and clinical trial design.

Preferred:

PhD in Skin Biology or related field, experience with novel aesthetic modalities (injectables, biologics, regenerative medicines), and previous regulatory and partnership experience.

HighValue:

focus on aesthetic dermatology, early-phase clinical trials, biomarker strategies, global regulatory engagement, matrix leadership, and external scientific influence.

WorkSetup:

multiple US locations (Boston, San Diego, San Francisco, Indianapolis); travel 10-15%.